pharmaceutical investing Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program
pharmaceutical investing Approval of Linzess Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation
LaFleur Minerals Files PEA Technical Report Supporting Restart of Gold Production at Beacon Gold Mill, Québec